AppointmentsAclaris Therapeutics CLO and co-founder to retire Nov 03, 2021Ben MaidenKamil Ali-Jackson, chief legal officer (CLO), chief compliance officer and corporate secretary with Nasdaq-listed Aclaris Therapeutics...Read more
